Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pleconaril. A broad spectrum antipicornaviral agent.

Literature DB >> 10549380

Pleconaril. A broad spectrum antipicornaviral agent.

J M Rogers¹, G D Diana, M A McKinlay.

Abstract

Mesh：

Substances：

Year: 1999 PMID： 10549380

Source DB: PubMed Journal: Adv Exp Med Biol ISSN： 0065-2598 Impact factor: 2.622

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Quantitative PCR-enhanced immunoassay for measurement of enteroviral immunoglobulin M antibody and diagnosis of aseptic meningitis.

Authors: Amal Elfaitouri; Nahla Mohamed; Jan Fohlman; Robert Aspholm; Gun Frisk; Göran Friman; Lars Magnius; Jonas Blomberg
Journal: Clin Diagn Lab Immunol Date: 2005-02

2. Structure and inhibition of EV-D68, a virus that causes respiratory illness in children.

Authors: Yue Liu; Ju Sheng; Andrei Fokine; Geng Meng; Woong-Hee Shin; Feng Long; Richard J Kuhn; Daisuke Kihara; Michael G Rossmann
Journal: Science Date: 2015-01-02 Impact factor: 47.728

3. Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone.

Authors: Shin-Ru Shih; Mun-Chung Tsai; Sung-Nien Tseng; Kuo-Fang Won; Kak-Shan Shia; Wen-Tai Li; Jyh-Haur Chern; Guang-Wu Chen; Chung-Chi Lee; Yen-Chun Lee; Kuan-Chang Peng; Yu-Sheng Chao
Journal: Antimicrob Agents Chemother Date: 2004-09 Impact factor: 5.191

Pleconaril. A broad spectrum antipicornaviral agent.

1. Quantitative PCR-enhanced immunoassay for measurement of enteroviral immunoglobulin M antibody and diagnosis of aseptic meningitis.

2. Structure and inhibition of EV-D68, a virus that causes respiratory illness in children.

3. Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone.

4. Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds.

5. Mechanism of action at the molecular level of the antiviral drug 3(2H)-isoflavene against type 2 poliovirus.

6. Atomic structure of a rhinovirus C, a virus species linked to severe childhood asthma.

7. Neonatal coxsackie B virus infection-a treatable disease?

8. Diagnosis and Management of Enteroviral Infections of the Central Nervous System.

9. Adenovirus as a new agent for multiple myeloma therapies: Opportunities and restrictions.

10. Oncolytic virotherapy for hematological malignancies.